Cite

HARVARD Citation

    Mukherjee, S. et al. (n.d.). 334 Phase II study evaluating a chemokine-modulatory (CKM) regimen in patients with colorectal cancer (CRC) metastatic to the liver. Journal for immunotherapy of cancer. p. A360. [Online]. 
  
Back to record